AU Patent

AU2020228289B2 — N-substituted indoles and other heterocycles for treating brain disorders

Assigned to University of California San Diego UCSD · Expires 2026-02-05 · 0y expired

What this patent protects

The present invention provides N-substituted indoles and other heterocycles and methods of using the compounds for treating brain disorders.

USPTO Abstract

The present invention provides N-substituted indoles and other heterocycles and methods of using the compounds for treating brain disorders.

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: AU2020228289B2
Jurisdiction: AU
Classification: —
Expires: 2026-02-05
Drug substance claim: No
Drug product claim: No
Assignee: University of California San Diego UCSD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.